Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

More Pressure On Pharma: UN Report Backs Compulsory Licensing

Sep 15 2016

• By Anju Ghangurde

UN access

Related Content

Cut price generics in sight as Gilead licenses Sovaldi

Sep 16 2014

Unlikely allies MSD, Cipla link to co-market Isentress in India

Feb 21 2014

India Compulsory Licensing: What USTR Hearing Transcripts Say

Apr 28 2016

UN Panel To Hear Stakeholder Ideas On IP, Innovation And Access

Mar 04 2016

PhRMA keeps eye on Indian compulsory licensing activity

Jul 13 2015

GSK Is First To Share Cancer Drug Patents With Poor Countries

Apr 01 2016

WHO's New Hepatitis C Drug Patent Profiles To Boost Access Worldwide

Jul 28 2016

Related Companies

Cipla Limited

Merck & Co., Inc.

GSK plc

Additional Topics

Intellectual Property Policy Regulation BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window